Paper Details

  1. Home
  2. Paper Details

Sumatriptan plus naproxen for acute migraine attacks in adults.

Author: DerrySheena, LawSimon, MooreR Andrew

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Migraine headaches are common and disabling, causing problems for individuals and healthcare systems. Triptans and nonsteroidal anti-inflammatory drugs (NSAIDs) are effective treatments for migraine attacks. These medications work in different ways, and combining them may provide better relief. A combination of sumatriptan and naproxen is now available for treating migraine headaches.
Paper Details　
Original Abstract of the Article :
Migraine is a common disabling condition and a burden for the individual, health services, and society. Effective abortive treatments include the triptan and non-steroidal anti-inflammatory classes of drugs. These drugs have different mechanisms of action and combining them may provide better relief...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD008541.pub2

データ提供：米国国立医学図書館（NLM）

Migraine: A Camel's Perspective on a Common Headache

Migraine is a common and often debilitating headache disorder, like a desert wind that whips across the mind. This study explored the efficacy of a combination therapy involving sumatriptan, a triptan medication, and naproxen, a non-steroidal anti-inflammatory drug, for the acute treatment of migraine attacks. The study suggests that this combination could provide better relief compared to using these medications separately, highlighting the potential of this approach for migraine management.

Sumatriptan plus Naproxen: A Double Oasis for Migraine Relief

This combination therapy has proven effective in reducing migraine symptoms. The study found that combining sumatriptan and naproxen offers a potential advantage over individual treatments, providing a potential for improved migraine relief.

Camel's Advice for Migraine Relief

If you suffer from migraines, it's essential to consult a doctor for proper diagnosis and treatment. Maintaining a healthy lifestyle, managing stress, and identifying migraine triggers can help minimize attacks. Keep your head up, and remember, there is relief to be found even in the desert of migraine pain!

Dr.Camel's Conclusion

This research sheds light on the potential benefits of combining sumatriptan and naproxen for the acute treatment of migraines. This approach offers hope for improved relief for those who suffer from this common and debilitating headache disorder. As we continue to explore the vast desert of migraine research, new treatments and therapies may emerge to offer a more comfortable journey for those affected.

Date :
  1. Date Completed 2014-04-28
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

24142431

DOI: Digital Object Identifier

10.1002/14651858.CD008541.pub2

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.